FDA.reportPublic FDA data

DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Substance profile for UNII 905HNO1SIH, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Structure render from PubChem CID 107676

Substance Identity#

UNII
905HNO1SIH
Preferred term
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Registry number
24938-16-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported
Chemical structure for DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Structure render from PubChem CID 107676

Chemical And Database Identifiers#

RxCUI
1311153
PubChem
107676
NCIt
C82310
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound107676https://pubchem.ncbi.nlm.nih.gov/compound/107676
RxNorm1311153https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1311153
NCI ThesaurusC82310https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82310
FDA Substance Registration System905HNO1SIHhttps://precision.fda.gov/uniisearch/srs/unii/905HNO1SIH

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHAZITHROMYCIN3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHFace Factor2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHBioFerr™ 901
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHThese highlights do not include all the information needed to use alfuzosin hydrochloride safely and effectively. See full prescribing information for alfuzosin hydrochloride extended-release tablets. Alfuzosin Hydrochloride Extended-Release Tablets Initial U.S. Approval: 20032
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts7
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts6
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDrug Facts2
Dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymerINACTIVE INGREDIENT905HNO1SIHNataFort ® PRENATAL MULTIVITAMIN TABLET WITH IRON1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPERPHENAZINE TABLETS, USP1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHFAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.]33
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHMIRTAZAPINE TABLET, ORALLY DISINTEGRATING [TEVA PHARMACEUTICALS USA INC]12
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHRISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN PHARMACEUTICALS INC.]12
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHCLOZAPINE TABLET, ORALLY DISINTEGRATING [TEVA PHARMACEUTICALS USA INC]11
Dimethylaminoethyl Methacrylate - Butyl Methacrylate - Methyl Methacrylate CopolymerINACTIVE INGREDIENT905HNO1SIHRISPERIDONE (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.]11
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHTRANEXAMIC ACID TABLET, FILM COATED [ACTAVIS PHARMA, INC.]10
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHLEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [ACTAVIS INC.]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHZECUITY (SUMATRIPTAN) PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED [NUPATHE INC.]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHZOLPIDEM TARTRATE TABLET, FILM COATED, EXTENDED RELEASE [WATSON LABORATORIES, INC.]8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHAZITHROMYCIN POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA INC]7
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHNIRAVAM (ALPRAZOLAM) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.]7
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHRISPERIDONE TABLET, ORALLY DISINTEGRATING [ZYDUS PHARMACEUTICALS (USA) INC.]7
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymerINACTIVE INGREDIENT905HNO1SIHZYRTEC (CETIRIZINE HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING [MCNEIL CONSUMER HEALTHCARE DIV. MCNEIL-PPC, INC]7
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]6
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHELEPSIA XR (LEVETIRACETAM) TABLET, EXTENDED RELEASE [SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED]5
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHMETOCLOPRAMIDE HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING [NOVEL LABORATORIES, INC.]5
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHRISPERIDONE TABLET, ORALLY DISINTEGRATING [CADILA HEALTHCARE LIMITED]5
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymerINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]4
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]4
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHAZITHROMYCIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.]3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHAZITHROMYCIN POWDER, FOR SUSPENSION [PROFICIENT RX LP]3
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymerINACTIVE INGREDIENT905HNO1SIHCHILDRENS ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING [JOHNSON & JOHNSON CONSUMER INC., MCNEIL CONSUMER HEALTHCARE DIVISION]3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHCIPROFLOXACIN ( CIPROFLOXACIN ) KIT [LUPIN PHARMACEUTICALS, INC.]3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [PROFICIENT RX LP]3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHRISPERIDONE TABLET, ORALLY DISINTEGRATING [MYLAN INSTITUTIONAL INC.]3
Dimethylaminoethyl Methacrylate - Butyl Methacrylate - Methyl Methacrylate CopolymerINACTIVE INGREDIENT905HNO1SIHZOLMITRIPTAN OD (ZOLMITRIPTAN) TABLET, ORALLY DISINTEGRATING [JUBILANT CADISTA PHARMACEUTICALS INC.]3
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET, FILM COATED [PROFICIENT RX LP]2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED]2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.]2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE) TABLET, ORALLY DISINTEGRATING [MYLAN PHARMACEUTICALS INC.]2
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHTRANEXAMIC ACID TABLET, FILM COATED [AMERICAN HEALTH PACKAGING]2
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymerINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED [AVKARE, INC.]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHATORVASTATIN CALCIUM TABLET, FILM COATED [NORTHWIND PHARMACEUTICALS]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHAZITHROMYCIN POWDER, FOR SUSPENSION [CLINICAL SOLUTIONS WHOLESALE]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHCITRANATAL B-CALM (ASCORBIC ACID, CALCIUM CITRATE, IRON, CHOLECALCIFEROL, PYRIDOXINE HYDROCHLORIDE, AND FOLIC ACID) KIT [MISSION PHARMACAL COMPANY]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDESLORATADINE TABLET, ORALLY DISINTEGRATING [ANESTA CORPORATION]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHDIVALPROEX SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHLAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHMETOCLOPRAMIDE HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING [GAVIS PHARMACEUTICALS, LLC]1
AMINO METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHOXYCODONE HYDROCHLORIDE (OXYCODONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ETHEX CORPORATION]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [REMEDYREPACK INC. ]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHPERPHENAZINE TABLET [REMEDYREPACK INC. ]1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHTHIOLA (TIOPRONIN) TABLET, SUGAR COATED [MISSION PHARMACAL COMPANY]1